Ma; Fupeng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ma; Fupeng.The latest application filed is for "1,2,4-oxadiazole derivatives as liver x receptor agonists".

Company Profile

4.28.31

Ma; Fupeng - Melrose MA
Ma; Fupeng - Cambridge MA
Ma; Fupeng - Toronto CA
Ma; Fupeng - Brampton CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,2,4-oxadiazole derivatives as liver X receptor agonists Grant 11,427,586 - Boss , et al. August 30, 2	2022-08-30
1,2,4-oxadiazole Derivatives As Liver X Receptor Agonists App 20220064164 - BOSS; Kelly D. ; et al.	2022-03-03
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Grant 11,185,537 - Beckwith , et al. November 30, 2	2021-11-30
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia App 20210284635 - BARBE; Guillaume ; et al.	2021-09-16
Naphthyridinone derivatives and their use in the treatment of arrhythmia Grant 10,844,055 - Barbe , et al. November 24, 2	2020-11-24
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives And Uses Thereof App 20200016143 - BECKWITH; Rohan Eric John ; et al.	2020-01-16
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia App 20190263803 - BARBE; Guillaume ; et al.	2019-08-29
Naphthyridinone derivatives and their use in the treatment of arrhythmia Grant 10,266,531 - Barbe , et al.	2019-04-23
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia App 20180111932 - BARBE; Guillaume ; et al.	2018-04-26
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis Grant RE46,558 - Sherris , et al. September 26, 2	2017-09-26
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,541,432 - Artman, III , et al. September 24, 2	2013-09-24
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,501,756 - Artman, III , et al. August 6, 2	2013-08-06
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,492,393 - Artman, III , et al. July 23, 2	2013-07-23
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,486,954 - Artman, III , et al. July 16, 2	2013-07-16
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,431,584 - Artman, III , et al. April 30, 2	2013-04-30
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 Grant 8,377,939 - Clayton , et al. February 19, 2	2013-02-19
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators--842 Grant 8,377,940 - Clayton , et al. February 19, 2	2013-02-19
Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130012529 - ARTMAN, III; Gerald David ; et al.	2013-01-10
Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005750 - ARTMAN, III; Gerald David ; et al.	2013-01-03
Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005753 - ARTMAN, III; Gerald David ; et al.	2013-01-03
Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005751 - ARTMAN, III; Gerald David ; et al.	2013-01-03
Heterobicyclic Carboxamides As Inhibitors For Kinases App 20120245187 - ARTMANN, III; Gerald David ; et al.	2012-09-27
Heterobicyclic carboxamides as inhibitors for kinases Grant 8,242,125 - Artman, III , et al. August 14, 2	2012-08-14
Metabotropic glutamate-receptor-potentiating isoindolones Grant 8,153,638 - Van Wagenen , et al. April 10, 2	2012-04-10
Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators App 20110166155 - VAN WAGENEN; Bradford ; et al.	2011-07-07
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,968,570 - Clayton , et al. June 28, 2	2011-06-28
AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 App 20110053953 - Slassi; Abdelmalik ; et al.	2011-03-03
Substituted isoindolones and their use as metabotropic glutamate receptor potentiators Grant 7,868,008 - Van Wagenen , et al. January 11, 2	2011-01-11
Metabotropic Glutamate-Receptor-Potentiating Isoindolones App 20100317674 - Van Wagenen; Bradford ; et al.	2010-12-16
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators App 20100280082 - Clayton; Joshua ; et al.	2010-11-04
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842 App 20100267740 - Clayton; Joshua ; et al.	2010-10-21
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,816,354 - Slassi , et al. October 19, 2	2010-10-19
Metabotropic glutamate-receptor-potentiating isoindolones Grant 7,807,706 - Van Wagenen , et al. October 5, 2	2010-10-05
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 Grant 7,799,792 - Clayton , et al. September 21, 2	2010-09-21
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,790,717 - Egle , et al. September 7, 2	2010-09-07
Heterobicyclic Carboxamides as inhibitors for kinases App 20100168082 - Artmann, III; Gerald David ; et al.	2010-07-01
Piperazine and Piperidine MGLUR5 Potentiators App 20100144710 - Arora; Jalaj ; et al.	2010-06-10
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators App 20090275578 - Clayton; Joshua ; et al.	2009-11-05
Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators App 20090192169 - Egle; Ian ; et al.	2009-07-30
Metabotropic Glutamate Receptor-Potentiating Isoindolones App 20090149505 - Empfield; James R. ; et al.	2009-06-11
Spiro-oxazolidinone Compounds And Their Use As Metabotropic Glutamate Receptor Potentiators App 20090124578 - EGLE; Ian ; et al.	2009-05-14
Substituted Isoindolones And Their Use As Metabotropic Glutamate Receptor Potentiators App 20090111830 - Wagenen; Bradford Van ; et al.	2009-04-30
Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders App 20090069340 - Balestra; Michael ; et al.	2009-03-12
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,485,722 - Egle , et al. February 3, 2	2009-02-03
Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators App 20090012089 - Slassi; Abdelmalik ; et al.	2009-01-08
Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators App 20080318999 - Isaac; Methvin ; et al.	2008-12-25
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 841 App 20080306088 - Clayton; Joshua ; et al.	2008-12-11
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842 App 20080306077 - Clayton; Joshua ; et al.	2008-12-11
Metabotropic Glutamate-Receptor-Potentiating Isoindolones App 20080227794 - Van Wagenen; Bradford ; et al.	2008-09-18
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators App 20080125431 - Egle; Ian ; et al.	2008-05-29
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators App 20070275966 - Slassi; Abdelmalik ; et al.	2007-11-29
Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators App 20070032469 - Isaac; Methvin ; et al.	2007-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.